Sponsor:
Vanderbilt University Medical Center
Code:
NCT06057675
Conditions
Postoperative Bleeding
Skin Cancer Face
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Accepted
Interventions
Treatment (tranexamic acid and 1% lidocaine with 1:100,000 epinephrine)
Control (1% lidocaine with 1:100,000 epinephrine)
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations
More Information
Trial information was received from ClinicalTrials.gov and was last updated on 2025-09-18. This information was provided to ClinicalTrials.gov by Vanderbilt University Medical Center on 2025-08-19.